Back

News

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...

Read More

[Article presse ] Par Frédéric Thual- La Tribune , à Nantes  |  26/03/2020, 15:08 Avec...

Read More

[Article Presse]   Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...

Read More

[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...

Read More

[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...

Read More

Nantes, September 11th, 2019 – XENOTHERA announces it has received  Czech Republic regulatory...

Read More

    XENOTHERA will participate at ESOT 2019 that will take place...

Read More

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

Read More

XENOTHERA has started to gather investors for a Series A round of...

Read More

Nantes, november 2017 The fresco, more than 8 meters long, has been...

Read More

Nantes, September 2017 We have been selected for the 2017 entrepreneur awards...

Read More

June 10th, 2016 XENOTHERA, a young biotech who develops an innovative immunosuppressant,...

Read More

September 1st, 2015 The Medicine Faculty of Nantes is welcoming the start-up...

Read More

July 24th, 2015 Several partners of XENOTHERA will be present at the...

Read More

July 23th, 2015 XENOTHERA will participate in the Biopharm America that will...

Read More